Researchers Pinpoint Neurons Behind Sleep Paralysis in Rats

When glutamate neurons are inactivated in rats, the rodents are still capable of REM sleep—but they lose the sleep paralysis unique to REM.

Written byJoshua A. Krisch
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Glutamate neurons emit a spontaneous red fluorescenceCNRS, SARA VALENCIA GARCIAOne of the early indications of Parkinson’s disease is REM sleep behavior disorder (RBD), which involves talking, kicking, and eventually falling out of bed during REM sleep—when the patient is supposed to be unable to move. Now, a December 12 study in Brain suggests that a similar condition exists in rats, and that a handful of glutamate neurons in the sublaterodorsal nucleus may be behind the phenomenon.

Researchers from Centre de Recherche en Neurosciences de Lyon and colleagues targeted glutamate neurons that prior studies had suggested were in part responsible for REM sleep. They introduced genetically modified viral vectors that targeted the neurons of the sublaterdorsal nuclei in rats and blocked the expression of a gene that causes glutamate secretion. They found that the rats were still capable of REM sleep, but that they were no longer unable to move. In fact, the rodents’ behaviors closely mimicked RBD.

The findings suggest that these neurons may be involved in the RBD parasomnia. The researchers are now developing an animal model of RBD.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies